ISRG - INTUITIVE SURGICAL INC
IEX Last Trade
538.64
-0.075 -0.014%
Share volume: 13,677
Last Updated: Thu 26 Dec 2024 06:30:04 PM CET
Surgical and Medical Instrument Manufacturing :
1.23%
PREVIOUS CLOSE
CHG
CHG%
$538.72
-0.08
-0.01%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-21 | 2023-02-10 | 2023-04-20 | 2023-07-24 | 2023-10-20 | 2024-01-31 | 2024-04-19 | 2024-07-19 | |
| Assets | |||||||||
| Total Assets | 13.261 B | 12.974 B | 13.053 B | 13.903 B | 14.713 B | 15.442 B | 15.828 B | 16.650 B | |
| Current Assets | 6.293 B | 6.253 B | 6.877 B | 8.032 B | 8.903 B | 7.888 B | 7.633 B | 7.654 B | |
| Inventories | 837.100 M | 893.200 M | 946.600 M | 1.005 B | 1.148 B | 1.221 B | 1.299 B | 1.384 B | |
| Other Current Assets | 287.400 M | 295.500 M | 312.900 M | 323.200 M | 317.000 M | 314.000 M | 405.400 M | 404.100 M | |
| Short Term Investments | 287.400 M | 295.500 M | 312.900 M | 323.200 M | 317.000 M | 314.000 M | 405.400 M | 404.100 M | |
| Total Receivables | 849.600 M | 942.100 M | 925.300 M | 904.200 M | 962.700 M | 1.130 B | 1.128 B | 1.109 B | |
| Current Cash | 4.319 B | 4.122 B | 4.692 B | 5.799 B | 6.476 B | 5.223 B | 4.800 B | 4.757 B | |
| Total Non-current Assets | 6.968 B | 6.721 B | 6.176 B | 5.872 B | 5.810 B | 7.554 B | 8.195 B | 8.996 B | |
| Property Plant Equipment | 2.244 B | 2.374 B | 2.580 B | 2.831 B | 3.077 B | 3.538 B | 3.800 B | 4.117 B | |
| Other Assets | 710.300 M | 710.100 M | 716.300 M | 693.100 M | 638.400 M | 636.700 M | 607.100 M | 658.000 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 348.200 M | 348.500 M | 348.600 M | 348.600 M | 348.100 M | 348.700 M | 348.200 M | 348.000 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 13.261 B | 12.974 B | 13.053 B | 13.903 B | 14.713 B | 15.442 B | 15.828 B | 16.650 B | |
| Total liabilities | 1.745 B | 1.932 B | 1.836 B | 2.024 B | 2.174 B | 2.134 B | 1.865 B | 1.942 B | |
| Total current liabilities | 1.233 B | 1.422 B | 1.307 B | 1.538 B | 1.676 B | 1.659 B | 1.375 B | 1.488 B | |
| Accounts Payable | 164.200 M | 147.000 M | 164.100 M | 199.700 M | 196.200 M | 188.700 M | 194.400 M | 194.400 M | |
| Other liabilities | 453.400 M | 439.300 M | 451.600 M | 405.200 M | 412.800 M | 385.500 M | 406.500 M | 365.900 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 453.400 M | 439.300 M | 451.600 M | 405.200 M | 412.800 M | 385.500 M | 406.500 M | 365.900 M | |
| Minority interest | 58.600 M | 70.700 M | 76.500 M | 80.600 M | 84.500 M | 89.700 M | 83.800 M | 88.200 M | |
| Total Shareholder equity | 11.515 B | 11.042 B | 11.218 B | 11.879 B | 12.539 B | 13.308 B | 13.963 B | 14.708 B | |
| Common stock | 355.300 M | 351.000 M | 350.200 M | 350.900 M | 351.700 M | 352.000 M | 353.500 M | 355.000 M | |
| Retained earnings | 4.018 B | 3.500 B | 3.397 B | 3.808 B | 4.209 B | 4.743 B | 5.068 B | 5.582 B |